Skip to main content
. 2023 Mar 13;29:10760296231162079. doi: 10.1177/10760296231162079

Figure 5.

Figure 5.

Alpha-2-Antiplasmin is significantly lower in patients with high-risk pulmonary embolism (PE) as compared to submassive and low-risk PE (P < .01)